Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

EVAX stock hub

Evaxion A/S has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

EVAXis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

36.2M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

EVAX

In the news

Latest news · EVAX

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-100.2

P25 -105.6P50 -46.5P75 -3.1

ROIC-35

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All EVAX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

201

Groups with data

Currency

USD

Showing 201 of 201 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001828253
Company name	Evaxion A/S
Country	Denmark
Country code	US
Cusip	29970R303
Employees	46
Employees Change	-3%
Employees Change Percent	-6.12
Enterprise value	$20.5M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2021-02-05
Isin	US29970R3030
Last refreshed	2026-05-10
Market cap	$36.2M
Market cap category	Nano-Cap
Price	$4.34
Price currency	USD
Rev Per Employee	163,652.17x
Sector	Healthcare
Sic	2836
Symbol	EVAX
Website	https://evaxion.ai

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-21.29%
EV/Sales	2.72x
FCF yield	-18.33%
P/B ratio	2.12x
P/S ratio	4.81x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-122.66%
EBITDA Margin	-117.87%
Gross margin	100%
Gross Profit	$7.5M
Gross Profit Growth	125.12%
Net Income	$-7.7M
Net Income Growth Years	4%
Pretax Margin	-114.44%
Profit Margin	-102.38%
Profit Per Employee	$-167,543
ROA	-28.23
Roa5y	-58.6
ROCE	-38.23
ROE	-100.2
ROIC	-34.99

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	193.46%
Cagr3y	-59.63%
Cagr5y	-57.99%
EPS Growth Years	4
Revenue Growth	125.12x
Revenue Growth Years	2x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.37
Assets	$28.4M
Cash	$23.2M
Current Assets	$24.9M
Current Liabilities	$4.3M
Debt	$7.5M
Debt Equity	$0.44
Equity	$17M
Interest Coverage	-10.54
Liabilities	$11.4M
Long Term Assets	$3.5M
Long Term Liabilities	$7.1M
Net Cash	$15.7M
Net Cash By Market Cap	$43.46
Net Debt Equity	$-0.92
Tangible Book Value	$17M
Tangible Book Value Per Share	$2.04
WACC	6.34

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	5.85
Net Working Capital	$-2M
Quick ratio	5.7
Working Capital	$20.6M
Working Capital Turnover	$0.6

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-497.28%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	193.24%
200-day SMA	4.33
3Y total return	-93.42%
50-day SMA	3.94
50-day SMA vs 200-day SMA	50under200
5Y total return	-98.69%
All Time High	1,252
All Time High Change	-99.65%
All Time High Date	2021-11-04
All Time Low	1.2
All Time Low Change	261.67%
All Time Low Date	2025-04-10
ATR	0.34
Beta	0.27
Beta1y	1.88
Beta2y	1.92
Ch YTD	-9.01
High	4.5
High52	12.15
High52 Date	2025-10-15
High52ch	-64.28%
Low	4.01
Low52	1.43
Low52 Date	2025-05-08
Low52ch	203.5%
Ma50ch	10.26%
Premarket Change Percent	2.46
Premarket Price	$4.17
Premarket Volume	255
Price vs 200-day SMA	0.23%
RSI	54.04
RSI Monthly	33.96
RSI Weekly	51.44
Sharpe ratio	1.44x
Sortino ratio	2.55
Total Return	-497.28%
Tr YTD	-9.01
Tr1m	14.21%
Tr1w	-3.45%
Tr3m	29.17%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	3
Analyst Count Top	1
Analyst Price Target Top	$16
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.23
Operating Income	$-9.2M
Operating margin	-122.7
Price target	$11.67
Price Target Change	$169
Price Target Change Top	$269

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	5,679,387%
Float Percent	68.1%
Net Borrowing	-751,000
Shares Insiders	2.79%
Shares Institutions	6.66%
Shares Out	8,340,215
Shares Qo Q	29.31%
Shares Yo Y	497.28%
Short Ratio	1.23
Short Shares	0.44

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-6.9M
Average Volume	32,690.1x
Bv Per Share	2.04
CAPEX	$-11,000
Ch1m	14.21
Ch1w	-3.45
Ch1y	193.2
Ch3m	29.17
Ch3y	-93.42
Ch5y	-98.69
Ch6m	-31.97
Change	6.63%
Change From Open	8.23
Close	4.07
Days Gap	-1.47
Depreciation Amortization	361,000
Dollar Volume	159,633.9
Earnings Date	2026-05-07
Earnings Time	bmo
EBIT	$-9.2M
EBITDA	$-8.9M
EPS	$-1.2
F Score	4
FCF	$-6.6M
FCF EV Yield	-32.42x
FCF Per Share	$-0.8
Financing CF	22,410,000
Fiscal Year End	December
Founded	2,008
Income Tax	$-908,000
Investing CF	-14,000
Ipr	-56.6
Iprfo	-99.13
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-07
Last Report Date	2025-12-31
Last Split Date	2025-01-14
Last Split Type	Reverse
Last10k Filing Date	2026-03-05
Ma150	4.75
Ma150ch	-8.63%
Ma20	4.3
Ma20ch	0.93%
Net CF	17,282,000
Next Earnings Date	2026-08-13
Open	4.01
Optionable	No
Position In Range	67.35
Post Close	4.34
Postmarket Change Percent	1.84
Postmarket Price	$4.42
Ppne	3,322,000
Pre Close	4.07
Price Date	2026-05-08
Ptbv Ratio	2.12
Relative Volume	1.13x
Revenue	7,528,000x
SBC By Revenue	4.08x
Share Based Comp	307,000
Tax By Revenue	-12.06x
Tr6m	-31.97%
Volume	36,782
Z Score	-5.01

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does EVAX pay a dividend?

Capital-return profile for this ticker.

Performance

EVAX stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns EVAX?

Insider, institutional, and short-interest positioning.

Institutional ownership

+6.7%

Float: +68.1% of shares outstanding

Insider ownership

+2.8%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

EVAX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

54.0

Neutral momentum band

Price vs 200-day MA

+0.2%

50/200-day relationship not available

Beta (5Y)

0.27

Less volatile than the market

Sharpe ratio

1.44

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About EVAX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current EVAX stock rating?

Evaxion A/S is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full EVAX analysis?

The full report lives at /stocks/EVAX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for EVAX?

The latest report frames EVAX around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the EVAX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.